| | | | | |
ANIK Anika Therapeutics Inc | €18.2284 | -1.34 % | €252.54M | €68.70K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | €8.9600 | -0.19 % | €252.47M | €1.21K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | €8.6003 | +0.00 % | €252.42M | €4.30K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | €36.1657 | -2.18 % | €252.29M | €23.60K | |
| €37.3820 | -3.34 % | €252.14M | €16.27K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | €8.5574 | -0.10 % | €252.14M | €6.01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | €8.6345 | +0.00 % | €252.13M | €142.62K | |
SLN Silence Therapeutics Plc American Depository Share | €11.6498 | -3.55 % | €252.07M | €834.17K | |
MTNE CH4 Natural Solutions Corporation | €8.4718 | +0.19 % | €251.74M | €2.91K | |
RXST RxSight, Inc. Common Stock | €5.2767 | -3.30 % | €251.53M | €530.47K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | €9.1057 | -0.19 % | €251.43M | €55.67K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | €8.5874 | +0.20 % | €251.40M | €239.68K | |
CNXU Conexeu Sciences Inc. Common Stock | €7.6280 | -10.90 % | €251.21M | €342.12K | |
| €8.7999 | +2.83 % | €250.96M | €1.07M | |
JCE Nuveen Core Equity Alpha Fund | €14.5322 | -0.67 % | €250.80M | €46.83K | |
